$808 Million is the total value of Rubric Capital Management LP's 49 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| COOP | New | MR COOPER GROUP INC | $47,847,000 | – | 4,100,000 | +100.0% | 5.92% | – |
| ZAYO | New | ZAYO GROUP HLDGS INC | $39,143,000 | – | 1,713,800 | +100.0% | 4.84% | – |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $30,115,000 | – | 814,357 | +100.0% | 3.73% | – |
| MYL | New | MYLAN N V | $27,674,000 | – | 1,010,000 | +100.0% | 3.42% | – |
| ARNA | New | ARENA PHARMACEUTICALS INC | $25,060,000 | – | 643,397 | +100.0% | 3.10% | – |
| AERI | New | AERIE PHARMACEUTICALS INC | $20,295,000 | – | 562,185 | +100.0% | 2.51% | – |
| HGV | New | HILTON GRAND VACATIONS INC | $12,858,000 | – | 487,220 | +100.0% | 1.59% | – |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDsponsored adr | $12,799,000 | – | 830,000 | +100.0% | 1.58% | – |
| FLEX | New | FLEX LTDord | $12,777,000 | – | 1,678,946 | +100.0% | 1.58% | – |
| BDSI | New | BIODELIVERY SCIENCES INTL IN | $7,385,000 | – | 1,995,959 | +100.0% | 0.91% | – |
| PRSP | New | PERSPECTA INC | $6,855,000 | – | 398,080 | +100.0% | 0.85% | – |
| TXMD | New | THERAPEUTICSMD INC | $5,887,000 | – | 1,545,228 | +100.0% | 0.73% | – |
| CBT | New | CABOT CORP | $4,608,000 | – | 107,301 | +100.0% | 0.57% | – |
| L100PS | New | ARCONIC INCcall | $3,372,000 | – | 200,000 | +100.0% | 0.42% | – |
| CLLS | New | CELLECTIS S Asponsored ads | $1,989,000 | – | 119,465 | +100.0% | 0.25% | – |
| OEC | New | ORION ENGINEERED CARBONS S A | $1,881,000 | – | 74,416 | +100.0% | 0.23% | – |
| TPCO | New | TRIBUNE PUBG CO NEW | $1,726,000 | – | 152,201 | +100.0% | 0.21% | – |
| EAGLW | New | PLATINUM EAGLE ACQUISITIN CO*w exp 01/17/202 | $845,000 | – | 650,000 | +100.0% | 0.10% | – |
| BERY | New | BERRY GLOBAL GROUP INC | $505,000 | – | 10,622 | +100.0% | 0.06% | – |
| PLYA | New | PLAYA HOTELS & RESORTS NV | $471,000 | – | 65,502 | +100.0% | 0.06% | – |
| MAS | New | MASCO CORP | $418,000 | – | 14,299 | +100.0% | 0.05% | – |
| LH | New | LABORATORY CORP AMER HLDGS | $371,000 | – | 2,934 | +100.0% | 0.05% | – |
| ATRS | New | ANTARES PHARMA INC | $35,000 | – | 12,865 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MAGNACHIP SEMICONDUCTOR CORP | 28 | Q3 2023 | 4.7% |
| BGC PARTNERS INC | 20 | Q2 2023 | 4.6% |
| MR COOPER GROUP INC | 20 | Q3 2023 | 5.9% |
| PAR PACIFIC HOLDINGS INC | 18 | Q3 2023 | 3.9% |
| RADIUS HEALTH INC | 16 | Q2 2022 | 4.3% |
| CLEAR CHANNEL OUTDOOR HLDGS | 16 | Q3 2023 | 2.6% |
| HERON THERAPEUTICS INC | 15 | Q3 2023 | 9.0% |
| COLLEGIUM PHARMACEUTICAL INC | 15 | Q3 2023 | 3.9% |
| AAR CORP | 14 | Q3 2023 | 3.2% |
| GREEN PLAINS INC | 14 | Q3 2022 | 4.1% |
View Rubric Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| HERON THERAPEUTICS, INC. /DE/ | July 25, 2023 | 26,713,503 | 19.0% |
| Amryt Pharma plc | February 10, 2023 | 18,000,000 | 5.6% |
| BGC Partners, Inc. | February 10, 2023 | 18,250,000 | 5.6% |
| EverQuote, Inc. | February 10, 2023 | 1,246,622 | 4.8% |
| Ferroglobe PLC | February 10, 2023 | 3,232,762 | 1.7% |
| Sio Gene Therapies Inc. | February 10, 2023 | 7,000,000 | 9.5% |
| Vincerx Pharma, Inc. | February 10, 2023 | 386,719 | 1.8% |
| Whole Earth Brands, Inc. | February 10, 2023 | 998,363 | 2.4% |
| Radius Health, Inc. | June 16, 2022 | 6,959,305 | 14.6% |
| ANTARES PHARMA, INC. | February 14, 2022 | 10,800,000 | 6.4% |
View Rubric Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| DFAN14A | 2024-05-16 |
| 13F-HR | 2024-05-10 |
| DFAN14A | 2024-05-08 |
| DFAN14A | 2024-05-03 |
| DFAN14A | 2024-05-01 |
| DFAN14A | 2024-04-30 |
| DFAN14A | 2024-04-29 |
| DEFC14A | 2024-04-17 |
| DFAN14A | 2024-04-17 |
| SC 13D/A | 2024-04-16 |
View Rubric Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.